M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 17.36 USD 5.08% Market Closed
Market Cap: $1.2B

Wall Street
Price Targets

MLTX Price Targets Summary
MoonLake Immunotherapeutics

Wall Street analysts forecast MLTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MLTX is 30.19 USD with a low forecast of 6.06 USD and a high forecast of 73.5 USD.

Lowest
Price Target
6.06 USD
65% Downside
Average
Price Target
30.19 USD
74% Upside
Highest
Price Target
73.5 USD
323% Upside
MoonLake Immunotherapeutics Competitors:
Price Targets
ACIU
AC Immune SA
233% Upside
WLFC
Willis Lease Finance Corp
10% Upside
LMB
Limbach Holdings Inc
56% Upside
TCPC
BlackRock TCP Capital Corp
23% Upside
CENT
Central Garden & Pet Co
37% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MLTX's stock price target?
Price Target
30.19 USD

According to Wall Street analysts, the average 1-year price target for MLTX is 30.19 USD with a low forecast of 6.06 USD and a high forecast of 73.5 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett